Search Results

There are 6325 results for: content related to: Designing Immunogens for Vaccine Development in Reference to HIV

  1. Understanding the binding mode and function of BMS-488043 against HIV-1 viral entry

    Proteins: Structure, Function, and Bioinformatics

    Volume 79, Issue 6, June 2011, Pages: 1810–1819, Lin-Tai Da, Jun-Min Quan and Yun-Dong Wu

    Version of Record online : 4 APR 2011, DOI: 10.1002/prot.23005

  2. You have full text access to this OnlineOpen article
    Homology models of the HIV-1 attachment inhibitor BMS-626529 bound to gp120 suggest a unique mechanism of action

    Proteins: Structure, Function, and Bioinformatics

    Volume 83, Issue 2, February 2015, Pages: 331–350, David R. Langley, S. Roy Kimura, Prasanna Sivaprakasam, Nannan Zhou, Ira Dicker, Brian McAuliffe, Tao Wang, John F. Kadow, Nicholas A. Meanwell and Mark Krystal

    Version of Record online : 23 DEC 2014, DOI: 10.1002/prot.24726

  3. You have free access to this content
    Differential recognition of epitopes present on monomeric and oligomeric forms of gp160 glycoprotein of human immunodeficiency virus type 1 by human monoclonal antibodies

    European Journal of Biochemistry

    Volume 268, Issue 10, May 2001, Pages: 2856–2866, Gabrielle Zeder-Lutz, Johan Hoebeke and Marc H. V. Van Regenmortel

    Version of Record online : 20 DEC 2001, DOI: 10.1046/j.1432-1327.2001.02167.x

  4. You have free access to this content
    Insights into vaccine development for acquired immune deficiency syndrome from crystal structures of human immunodeficiency virus-1 gp41 and equine infectious anemia virus gp45

    Protein Science

    Volume 24, Issue 10, October 2015, Pages: 1549–1559, Liangwei Duan, Jiansen Du and Xinqi Liu

    Version of Record online : 21 SEP 2015, DOI: 10.1002/pro.2750

  5. The envelope glycoprotein of HIV-1 gp120 and human complement protein C1q bind to the same peptides derived from three different regions of gp41, the transmembrane glycoprotein of HIV-1, and share antigenic homology

    European Journal of Immunology

    Volume 24, Issue 2, February 1994, Pages: 294–300, Heribert Stoiber, Christoph Ebenbichler, Manfred P. Dierich, Nicole M. Thiele and Gerard J. Arlaud

    Version of Record online : 23 NOV 2005, DOI: 10.1002/eji.1830240203

  6. Structural requirements for and consequences of an antiviral porphyrin binding to the V3 loop of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp120

    Journal of Molecular Recognition

    Volume 8, Issue 6, November/December 1995, Pages: 345–357, A. Robert Neurath, Nathan Strick and Asim K. Debnath

    Version of Record online : 3 FEB 2004, DOI: 10.1002/jmr.300080604

  7. HIV entry inhibitors and their potential in HIV therapy

    Medicinal Research Reviews

    Volume 29, Issue 2, March 2009, Pages: 369–393, Keduo Qian, Susan L. Morris-Natschke and Kuo-Hsiung Lee

    Version of Record online : 21 AUG 2008, DOI: 10.1002/med.20138

  8. Neutralization of human immunodeficiency virus

    Reviews in Medical Virology

    Volume 2, Issue 1, March 1992, Pages: 35–42, Jane A. Mckeating

    Version of Record online : 18 OCT 2005, DOI: 10.1002/rmv.1980020106

  9. Prediction of the secondary structure of HIV-1 gp120

    Proteins: Structure, Function, and Bioinformatics

    Volume 25, Issue 1, May 1996, Pages: 1–11, Jan E. Hansen, Ole Lund, Jens O. Nielsen, Søren Brunak and John-E. S. Hansen

    Version of Record online : 7 DEC 1998, DOI: 10.1002/(SICI)1097-0134(199605)25:1<1::AID-PROT1>3.0.CO;2-N

  10. Structural Characteristics Predict the Stability of HIV

    Development of Vaccines: From Discovery to Clinical Testing

    Zohar Biron-Sorek, Yide Sun, Elaine Kan, Jeanne Flandez, Michael Franti, Jeffrey Ulmer, Susan Barnett, Indresh K. Srivastava, Pages: 305–325, 2011

    Published Online : 6 JUN 2011, DOI: 10.1002/9781118023648.ch12

  11. Carbohydrate-Based Antiviral Vaccines

    Carbohydrate-Based Vaccines and Immunotherapies

    Benjamin M. Swarts, Zhongwu Guo, Pages: 167–193, 2008

    Published Online : 28 OCT 2008, DOI: 10.1002/9780470473283.ch5

  12. The complex antigenicity of a small external region of the C-terminal tail of the HIV-1 gp41 envelope protein: a lesson in epitope analysis

    Reviews in Medical Virology

    Volume 15, Issue 6, November/December 2005, Pages: 365–381, Nigel J. Dimmock

    Version of Record online : 17 AUG 2005, DOI: 10.1002/rmv.476

  13. CD4 activation of HIV fusion

    The International Journal of Cell Cloning

    Volume 10, Issue 6, 1992, Pages: 323–332, Quentin J. Sattentau

    Version of Record online : 1 JAN 1996, DOI: 10.1002/stem.5530100603

  14. The Prevention of HIV Infection with Viral Entry Inhibitors

    Peptides as Drugs: Discovery and Development

    Lisa Egerer, Anne Hubert, Dorothee von Laer, Ursula Dietrich, Pages: 73–102, 2009

    Published Online : 14 AUG 2009, DOI: 10.1002/9783527626830.ch5

  15. HIV-1 ENV gp120 structural determinants for peptide triazole dual receptor site antagonism

    Proteins: Structure, Function, and Bioinformatics

    Volume 81, Issue 2, February 2013, Pages: 271–290, Ferit Tuzer, Navid Madani, Kantharaju Kamanna, Isaac Zentner, Judith LaLonde, Andrew Holmes, Elizabeth Upton, Srivats Rajagopal, Karyn McFadden, Mark Contarino, Joseph Sodroski and Irwin Chaiken

    Version of Record online : 26 OCT 2012, DOI: 10.1002/prot.24184

  16. Immune evasion strategies of the primate lentiviruses

    Immunological Reviews

    Volume 183, Issue 1, October 2001, Pages: 141–158, David T. Evans and Ronald C. Desrosiers

    Version of Record online : 5 JAN 2002, DOI: 10.1034/j.1600-065x.2001.1830112.x

  17. You have free access to this content
    Quaternary protein mimetics of gp41 elicit neutralizing antibodies against HIV fusion-active intermediate state

    Peptide Science

    Volume 90, Issue 3, 2008, Pages: 320–329, Kristen Sadler, Ying Zhang, Jiaxi Xu, Qitao Yu and James P. Tam

    Version of Record online : 12 MAR 2008, DOI: 10.1002/bip.20979

  18. You have free access to this content
    Detection of IgA-Binding Sites on Human Immunodeficiency Virus Type-1 Envelope Glycoproteins, Gp120 and Gp41

    Microbiology and Immunology

    Volume 44, Issue 11, November 2000, Pages: 923–929, Shunji Matsuda and Masahiro Noda

    Version of Record online : 14 NOV 2013, DOI: 10.1111/j.1348-0421.2000.tb02584.x

  19. You have free access to this content
    Human-immunodeficiency-virus transmembrane glycoprotein gp41 is an amino acceptor and donor substrate for transglutaminase in vitro

    European Journal of Biochemistry

    Volume 215, Issue 1, July 1993, Pages: 99–104, Loredana MARINEILLO, Carla ESPOSITO, Prospero DI PIERRO, Anna COZZOLINO, Pietro PUCCI and Raffaele PORTA

    Version of Record online : 3 MAR 2005, DOI: 10.1111/j.1432-1033.1993.tb18011.x

  20. Prevention and treatment of AIDS

    Journal of Cellular Biochemistry

    Volume 56, Issue S18B, 21 January 1994, Pages: 107–168,

    Version of Record online : 19 FEB 2004, DOI: 10.1002/jcb.240560604